nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—CACNA1C—attention deficit hyperactivity disorder	0.759	1	CbGaD
Bepridil—CALM1—autonomic nervous system—attention deficit hyperactivity disorder	0.00459	0.0487	CbGeAlD
Bepridil—CACNA1A—forebrain—attention deficit hyperactivity disorder	0.00376	0.0398	CbGeAlD
Bepridil—PDE1B—forebrain—attention deficit hyperactivity disorder	0.00328	0.0348	CbGeAlD
Bepridil—PDE1A—forebrain—attention deficit hyperactivity disorder	0.00275	0.0291	CbGeAlD
Bepridil—TNNC1—cardiovascular system—attention deficit hyperactivity disorder	0.00266	0.0282	CbGeAlD
Bepridil—PDE1A—cardiovascular system—attention deficit hyperactivity disorder	0.00232	0.0246	CbGeAlD
Bepridil—KCNQ1—cardiovascular system—attention deficit hyperactivity disorder	0.00216	0.0229	CbGeAlD
Bepridil—CACNA1A—nervous system—attention deficit hyperactivity disorder	0.00204	0.0216	CbGeAlD
Bepridil—CACNA1A—central nervous system—attention deficit hyperactivity disorder	0.00197	0.0208	CbGeAlD
Bepridil—CACNA1A—cerebellum—attention deficit hyperactivity disorder	0.00192	0.0204	CbGeAlD
Bepridil—PDE1A—midbrain—attention deficit hyperactivity disorder	0.00182	0.0192	CbGeAlD
Bepridil—CACNA1H—cardiovascular system—attention deficit hyperactivity disorder	0.00181	0.0192	CbGeAlD
Bepridil—PDE1B—nervous system—attention deficit hyperactivity disorder	0.00178	0.0189	CbGeAlD
Bepridil—CACNA1D—forebrain—attention deficit hyperactivity disorder	0.00177	0.0188	CbGeAlD
Bepridil—CACNA2D2—midbrain—attention deficit hyperactivity disorder	0.00175	0.0185	CbGeAlD
Bepridil—PDE1B—central nervous system—attention deficit hyperactivity disorder	0.00171	0.0182	CbGeAlD
Bepridil—PDE1B—cerebellum—attention deficit hyperactivity disorder	0.00168	0.0178	CbGeAlD
Bepridil—CACNA1C—forebrain—attention deficit hyperactivity disorder	0.00164	0.0173	CbGeAlD
Bepridil—CACNA1A—brain—attention deficit hyperactivity disorder	0.00156	0.0165	CbGeAlD
Bepridil—CACNA1D—cardiovascular system—attention deficit hyperactivity disorder	0.0015	0.0159	CbGeAlD
Bepridil—PDE1A—nervous system—attention deficit hyperactivity disorder	0.00149	0.0158	CbGeAlD
Bepridil—PDE1A—central nervous system—attention deficit hyperactivity disorder	0.00144	0.0152	CbGeAlD
Bepridil—CACNA2D2—nervous system—attention deficit hyperactivity disorder	0.00144	0.0152	CbGeAlD
Bepridil—PDE1A—cerebellum—attention deficit hyperactivity disorder	0.0014	0.0149	CbGeAlD
Bepridil—CACNA2D2—central nervous system—attention deficit hyperactivity disorder	0.00138	0.0147	CbGeAlD
Bepridil—CACNA1C—cardiovascular system—attention deficit hyperactivity disorder	0.00138	0.0147	CbGeAlD
Bepridil—PDE1B—brain—attention deficit hyperactivity disorder	0.00136	0.0144	CbGeAlD
Bepridil—CACNA2D2—cerebellum—attention deficit hyperactivity disorder	0.00135	0.0143	CbGeAlD
Bepridil—Phenoxybenzamine—ADRA2C—attention deficit hyperactivity disorder	0.00124	0.307	CrCbGaD
Bepridil—ATP1A1—forebrain—attention deficit hyperactivity disorder	0.00122	0.0129	CbGeAlD
Bepridil—CACNA1H—nervous system—attention deficit hyperactivity disorder	0.00117	0.0123	CbGeAlD
Bepridil—Diphenylpyraline—SLC6A3—attention deficit hyperactivity disorder	0.00114	0.284	CrCbGaD
Bepridil—PDE1A—brain—attention deficit hyperactivity disorder	0.00114	0.0121	CbGeAlD
Bepridil—CACNA2D2—brain—attention deficit hyperactivity disorder	0.0011	0.0116	CbGeAlD
Bepridil—CACNA1H—cerebellum—attention deficit hyperactivity disorder	0.0011	0.0116	CbGeAlD
Bepridil—CALM2—forebrain—attention deficit hyperactivity disorder	0.00108	0.0114	CbGeAlD
Bepridil—CALM1—forebrain—attention deficit hyperactivity disorder	0.00107	0.0113	CbGeAlD
Bepridil—KCNQ1—brain—attention deficit hyperactivity disorder	0.00106	0.0112	CbGeAlD
Bepridil—ATP1A1—cardiovascular system—attention deficit hyperactivity disorder	0.00103	0.0109	CbGeAlD
Bepridil—KCNH2—forebrain—attention deficit hyperactivity disorder	0.000974	0.0103	CbGeAlD
Bepridil—CACNA1D—nervous system—attention deficit hyperactivity disorder	0.000962	0.0102	CbGeAlD
Bepridil—CACNA1D—central nervous system—attention deficit hyperactivity disorder	0.000926	0.00981	CbGeAlD
Bepridil—CALM2—cardiovascular system—attention deficit hyperactivity disorder	0.00091	0.00964	CbGeAlD
Bepridil—CALM1—cardiovascular system—attention deficit hyperactivity disorder	0.000905	0.00959	CbGeAlD
Bepridil—CACNA1D—cerebellum—attention deficit hyperactivity disorder	0.000905	0.00959	CbGeAlD
Bepridil—CALM3—midbrain—attention deficit hyperactivity disorder	0.000904	0.00959	CbGeAlD
Bepridil—CACNA1H—brain—attention deficit hyperactivity disorder	0.00089	0.00944	CbGeAlD
Bepridil—CACNA1C—nervous system—attention deficit hyperactivity disorder	0.000888	0.00941	CbGeAlD
Bepridil—CACNA1C—central nervous system—attention deficit hyperactivity disorder	0.000855	0.00906	CbGeAlD
Bepridil—CACNA1C—cerebellum—attention deficit hyperactivity disorder	0.000835	0.00885	CbGeAlD
Bepridil—KCNH2—cardiovascular system—attention deficit hyperactivity disorder	0.000824	0.00873	CbGeAlD
Bepridil—ATP1A1—midbrain—attention deficit hyperactivity disorder	0.000807	0.00855	CbGeAlD
Bepridil—CACNA1D—brain—attention deficit hyperactivity disorder	0.000735	0.00779	CbGeAlD
Bepridil—CALM2—midbrain—attention deficit hyperactivity disorder	0.00071	0.00753	CbGeAlD
Bepridil—CALM1—midbrain—attention deficit hyperactivity disorder	0.000707	0.00749	CbGeAlD
Bepridil—CALM3—cerebellum—attention deficit hyperactivity disorder	0.0007	0.00742	CbGeAlD
Bepridil—CACNA1C—brain—attention deficit hyperactivity disorder	0.000679	0.00719	CbGeAlD
Bepridil—ATP1A1—nervous system—attention deficit hyperactivity disorder	0.000663	0.00703	CbGeAlD
Bepridil—KCNH2—midbrain—attention deficit hyperactivity disorder	0.000643	0.00682	CbGeAlD
Bepridil—ATP1A1—central nervous system—attention deficit hyperactivity disorder	0.000638	0.00677	CbGeAlD
Bepridil—ATP1A1—cerebellum—attention deficit hyperactivity disorder	0.000624	0.00661	CbGeAlD
Bepridil—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000594	0.0063	CbGeAlD
Bepridil—CALM2—nervous system—attention deficit hyperactivity disorder	0.000584	0.00619	CbGeAlD
Bepridil—CALM1—nervous system—attention deficit hyperactivity disorder	0.000581	0.00616	CbGeAlD
Bepridil—CALM3—brain—attention deficit hyperactivity disorder	0.000568	0.00602	CbGeAlD
Bepridil—Benzphetamine—SLC6A3—attention deficit hyperactivity disorder	0.000563	0.14	CrCbGaD
Bepridil—CALM2—central nervous system—attention deficit hyperactivity disorder	0.000562	0.00596	CbGeAlD
Bepridil—CALM1—central nervous system—attention deficit hyperactivity disorder	0.00056	0.00593	CbGeAlD
Bepridil—Benzphetamine—ADRA2A—attention deficit hyperactivity disorder	0.000552	0.137	CrCbGaD
Bepridil—CALM2—cerebellum—attention deficit hyperactivity disorder	0.000549	0.00582	CbGeAlD
Bepridil—CALM1—cerebellum—attention deficit hyperactivity disorder	0.000547	0.0058	CbGeAlD
Bepridil—KCNH2—nervous system—attention deficit hyperactivity disorder	0.000529	0.00561	CbGeAlD
Bepridil—Phenoxybenzamine—ADRA2A—attention deficit hyperactivity disorder	0.000528	0.131	CrCbGaD
Bepridil—KCNH2—central nervous system—attention deficit hyperactivity disorder	0.000509	0.0054	CbGeAlD
Bepridil—ATP1A1—brain—attention deficit hyperactivity disorder	0.000507	0.00537	CbGeAlD
Bepridil—KCNH2—cerebellum—attention deficit hyperactivity disorder	0.000498	0.00528	CbGeAlD
Bepridil—CALM2—brain—attention deficit hyperactivity disorder	0.000446	0.00473	CbGeAlD
Bepridil—CALM1—brain—attention deficit hyperactivity disorder	0.000444	0.00471	CbGeAlD
Bepridil—ABCB1—forebrain—attention deficit hyperactivity disorder	0.000427	0.00453	CbGeAlD
Bepridil—KCNH2—brain—attention deficit hyperactivity disorder	0.000404	0.00428	CbGeAlD
Bepridil—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.000361	0.00383	CbGeAlD
Bepridil—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000323	0.00342	CbGeAlD
Bepridil—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000311	0.00329	CbGeAlD
Bepridil—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000304	0.00322	CbGeAlD
Bepridil—ABCB1—midbrain—attention deficit hyperactivity disorder	0.000282	0.00299	CbGeAlD
Bepridil—CYP2D6—brain—attention deficit hyperactivity disorder	0.000247	0.00261	CbGeAlD
Bepridil—ABCB1—nervous system—attention deficit hyperactivity disorder	0.000232	0.00246	CbGeAlD
Bepridil—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000223	0.00237	CbGeAlD
Bepridil—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.000218	0.00231	CbGeAlD
Bepridil—ABCB1—brain—attention deficit hyperactivity disorder	0.000177	0.00188	CbGeAlD
Bepridil—CALM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	6.84e-05	0.000478	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	6.84e-05	0.000478	CbGpPWpGaD
Bepridil—PDE1B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	6.84e-05	0.000477	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	6.79e-05	0.000474	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	6.79e-05	0.000474	CbGpPWpGaD
Bepridil—CACNA1A—Metabolism—COMT—attention deficit hyperactivity disorder	6.65e-05	0.000465	CbGpPWpGaD
Bepridil—CACNA1A—Metabolism—MAOA—attention deficit hyperactivity disorder	6.61e-05	0.000461	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	6.6e-05	0.000461	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	6.56e-05	0.000458	CbGpPWpGaD
Bepridil—CALM3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	6.55e-05	0.000457	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	6.39e-05	0.000447	CbGpPWpGaD
Bepridil—PDE1B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	6.37e-05	0.000445	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	6.35e-05	0.000444	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	6.35e-05	0.000444	CbGpPWpGaD
Bepridil—CALM2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	6.33e-05	0.000442	CbGpPWpGaD
Bepridil—CALM1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	6.33e-05	0.000442	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	6.32e-05	0.000442	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	6.28e-05	0.000439	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	6.21e-05	0.000434	CbGpPWpGaD
Bepridil—PDE1A—Disease—SNAP25—attention deficit hyperactivity disorder	6.09e-05	0.000425	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.97e-05	0.000417	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—TPH2—attention deficit hyperactivity disorder	5.97e-05	0.000417	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—DPYD—attention deficit hyperactivity disorder	5.88e-05	0.00041	CbGpPWpGaD
Bepridil—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	5.85e-05	0.000409	CbGpPWpGaD
Bepridil—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	5.81e-05	0.000406	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	5.78e-05	0.000404	CbGpPWpGaD
Bepridil—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	5.77e-05	0.000403	CbGpPWpGaD
Bepridil—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	5.73e-05	0.0004	CbGpPWpGaD
Bepridil—CACNA1H—Developmental Biology—EP300—attention deficit hyperactivity disorder	5.66e-05	0.000396	CbGpPWpGaD
Bepridil—CACNA2D2—Metabolism—COMT—attention deficit hyperactivity disorder	5.58e-05	0.000389	CbGpPWpGaD
Bepridil—PDE1B—Disease—SNAP25—attention deficit hyperactivity disorder	5.57e-05	0.000389	CbGpPWpGaD
Bepridil—CALM3—Neuronal System—COMT—attention deficit hyperactivity disorder	5.57e-05	0.000389	CbGpPWpGaD
Bepridil—CACNA2D2—Metabolism—MAOA—attention deficit hyperactivity disorder	5.54e-05	0.000387	CbGpPWpGaD
Bepridil—CALM3—Neuronal System—MAOA—attention deficit hyperactivity disorder	5.53e-05	0.000386	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	5.47e-05	0.000382	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.46e-05	0.000382	CbGpPWpGaD
Bepridil—CALM2—Neuronal System—COMT—attention deficit hyperactivity disorder	5.38e-05	0.000376	CbGpPWpGaD
Bepridil—CALM1—Neuronal System—COMT—attention deficit hyperactivity disorder	5.38e-05	0.000376	CbGpPWpGaD
Bepridil—CALM2—Neuronal System—MAOA—attention deficit hyperactivity disorder	5.35e-05	0.000373	CbGpPWpGaD
Bepridil—CALM1—Neuronal System—MAOA—attention deficit hyperactivity disorder	5.35e-05	0.000373	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—TPH2—attention deficit hyperactivity disorder	5.25e-05	0.000367	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.25e-05	0.000367	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	5.25e-05	0.000367	CbGpPWpGaD
Bepridil—CALM3—Immune System—MB21D1—attention deficit hyperactivity disorder	5.21e-05	0.000364	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—DPYD—attention deficit hyperactivity disorder	5.16e-05	0.000361	CbGpPWpGaD
Bepridil—CALM3—Immune System—STUB1—attention deficit hyperactivity disorder	5.04e-05	0.000352	CbGpPWpGaD
Bepridil—CALM2—Immune System—MB21D1—attention deficit hyperactivity disorder	5.04e-05	0.000352	CbGpPWpGaD
Bepridil—CALM1—Immune System—MB21D1—attention deficit hyperactivity disorder	5.04e-05	0.000352	CbGpPWpGaD
Bepridil—CALM2—Immune System—STUB1—attention deficit hyperactivity disorder	4.88e-05	0.000341	CbGpPWpGaD
Bepridil—CALM1—Immune System—STUB1—attention deficit hyperactivity disorder	4.88e-05	0.000341	CbGpPWpGaD
Bepridil—PDE1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	4.88e-05	0.000341	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	4.8e-05	0.000335	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.78e-05	0.000334	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	4.74e-05	0.000331	CbGpPWpGaD
Bepridil—CALM3—Disease—STUB1—attention deficit hyperactivity disorder	4.66e-05	0.000325	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	4.65e-05	0.000325	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	4.59e-05	0.000321	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	4.59e-05	0.000321	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.59e-05	0.00032	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.55e-05	0.000318	CbGpPWpGaD
Bepridil—CALM1—Disease—STUB1—attention deficit hyperactivity disorder	4.51e-05	0.000315	CbGpPWpGaD
Bepridil—CALM2—Disease—STUB1—attention deficit hyperactivity disorder	4.51e-05	0.000315	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	4.5e-05	0.000314	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	4.5e-05	0.000314	CbGpPWpGaD
Bepridil—PDE1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	4.46e-05	0.000312	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.43e-05	0.000309	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	4.34e-05	0.000303	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.26e-05	0.000298	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	4.2e-05	0.000293	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	4.2e-05	0.000293	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.2e-05	0.000293	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.2e-05	0.000293	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	4.18e-05	0.000292	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.13e-05	0.000288	CbGpPWpGaD
Bepridil—PDE1A—Hemostasis—EP300—attention deficit hyperactivity disorder	4.09e-05	0.000286	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.06e-05	0.000284	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.05e-05	0.000283	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	4.04e-05	0.000282	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	4.04e-05	0.000282	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.01e-05	0.00028	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.99e-05	0.000279	CbGpPWpGaD
Bepridil—CACNA1D—Developmental Biology—EP300—attention deficit hyperactivity disorder	3.9e-05	0.000273	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.9e-05	0.000272	CbGpPWpGaD
Bepridil—CALM3—Immune System—POLR3A—attention deficit hyperactivity disorder	3.82e-05	0.000267	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.78e-05	0.000264	CbGpPWpGaD
Bepridil—PDE1B—Hemostasis—EP300—attention deficit hyperactivity disorder	3.74e-05	0.000261	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.73e-05	0.000261	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.71e-05	0.000259	CbGpPWpGaD
Bepridil—CALM2—Immune System—POLR3A—attention deficit hyperactivity disorder	3.7e-05	0.000258	CbGpPWpGaD
Bepridil—CALM1—Immune System—POLR3A—attention deficit hyperactivity disorder	3.7e-05	0.000258	CbGpPWpGaD
Bepridil—PDE1A—Innate Immune System—EP300—attention deficit hyperactivity disorder	3.68e-05	0.000257	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.67e-05	0.000256	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—COMT—attention deficit hyperactivity disorder	3.62e-05	0.000253	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—MAOA—attention deficit hyperactivity disorder	3.59e-05	0.000251	CbGpPWpGaD
Bepridil—CACNA1C—Developmental Biology—EP300—attention deficit hyperactivity disorder	3.43e-05	0.000239	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.42e-05	0.000239	CbGpPWpGaD
Bepridil—PDE1B—Innate Immune System—EP300—attention deficit hyperactivity disorder	3.37e-05	0.000235	CbGpPWpGaD
Bepridil—CALM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.35e-05	0.000234	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.26e-05	0.000228	CbGpPWpGaD
Bepridil—CALM2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.24e-05	0.000226	CbGpPWpGaD
Bepridil—CALM1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.24e-05	0.000226	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.22e-05	0.000225	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—COMT—attention deficit hyperactivity disorder	3.18e-05	0.000222	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—MAOA—attention deficit hyperactivity disorder	3.16e-05	0.000221	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.15e-05	0.00022	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.15e-05	0.00022	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.12e-05	0.000218	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.12e-05	0.000218	CbGpPWpGaD
Bepridil—CACNA1A—Metabolism—EP300—attention deficit hyperactivity disorder	2.85e-05	0.000199	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.82e-05	0.000197	CbGpPWpGaD
Bepridil—CALM3—RNF mutants show enhanced WNT signaling and proliferation—EP300—attention deficit hyperactivity disorder	2.81e-05	0.000197	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.8e-05	0.000196	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.75e-05	0.000192	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.72e-05	0.00019	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.72e-05	0.00019	CbGpPWpGaD
Bepridil—CALM2—RNF mutants show enhanced WNT signaling and proliferation—EP300—attention deficit hyperactivity disorder	2.72e-05	0.00019	CbGpPWpGaD
Bepridil—CALM1—RNF mutants show enhanced WNT signaling and proliferation—EP300—attention deficit hyperactivity disorder	2.72e-05	0.00019	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.71e-05	0.000189	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.71e-05	0.000189	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.69e-05	0.000188	CbGpPWpGaD
Bepridil—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	2.67e-05	0.000186	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.66e-05	0.000185	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.66e-05	0.000185	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.62e-05	0.000183	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.62e-05	0.000183	CbGpPWpGaD
Bepridil—CALM3—Signaling by WNT in cancer—EP300—attention deficit hyperactivity disorder	2.61e-05	0.000183	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.6e-05	0.000182	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.6e-05	0.000182	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.54e-05	0.000177	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.54e-05	0.000177	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.53e-05	0.000177	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.53e-05	0.000177	CbGpPWpGaD
Bepridil—CALM1—Signaling by WNT in cancer—EP300—attention deficit hyperactivity disorder	2.53e-05	0.000177	CbGpPWpGaD
Bepridil—CALM2—Signaling by WNT in cancer—EP300—attention deficit hyperactivity disorder	2.53e-05	0.000177	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.49e-05	0.000174	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.46e-05	0.000172	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.45e-05	0.000171	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.45e-05	0.000171	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	2.45e-05	0.000171	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.41e-05	0.000168	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.41e-05	0.000168	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.39e-05	0.000167	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.39e-05	0.000167	CbGpPWpGaD
Bepridil—CACNA2D2—Metabolism—EP300—attention deficit hyperactivity disorder	2.39e-05	0.000167	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.38e-05	0.000166	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.38e-05	0.000166	CbGpPWpGaD
Bepridil—CALM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.31e-05	0.000162	CbGpPWpGaD
Bepridil—CALM3—Metabolism—TPH2—attention deficit hyperactivity disorder	2.31e-05	0.000162	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.29e-05	0.00016	CbGpPWpGaD
Bepridil—CALM3—Metabolism—DPYD—attention deficit hyperactivity disorder	2.28e-05	0.000159	CbGpPWpGaD
Bepridil—CALM2—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.24e-05	0.000156	CbGpPWpGaD
Bepridil—CALM1—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.24e-05	0.000156	CbGpPWpGaD
Bepridil—CALM2—Metabolism—TPH2—attention deficit hyperactivity disorder	2.24e-05	0.000156	CbGpPWpGaD
Bepridil—CALM1—Metabolism—TPH2—attention deficit hyperactivity disorder	2.24e-05	0.000156	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.22e-05	0.000155	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.22e-05	0.000155	CbGpPWpGaD
Bepridil—CALM3—Disease—SNAP25—attention deficit hyperactivity disorder	2.21e-05	0.000154	CbGpPWpGaD
Bepridil—CALM2—Metabolism—DPYD—attention deficit hyperactivity disorder	2.2e-05	0.000154	CbGpPWpGaD
Bepridil—CALM1—Metabolism—DPYD—attention deficit hyperactivity disorder	2.2e-05	0.000154	CbGpPWpGaD
Bepridil—CALM3—Signaling by Wnt—EP300—attention deficit hyperactivity disorder	2.15e-05	0.000151	CbGpPWpGaD
Bepridil—PDE1A—Immune System—EP300—attention deficit hyperactivity disorder	2.14e-05	0.00015	CbGpPWpGaD
Bepridil—CALM2—Disease—SNAP25—attention deficit hyperactivity disorder	2.14e-05	0.000149	CbGpPWpGaD
Bepridil—CALM1—Disease—SNAP25—attention deficit hyperactivity disorder	2.14e-05	0.000149	CbGpPWpGaD
Bepridil—CALM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.12e-05	0.000148	CbGpPWpGaD
Bepridil—CALM2—Signaling by Wnt—EP300—attention deficit hyperactivity disorder	2.08e-05	0.000146	CbGpPWpGaD
Bepridil—CALM1—Signaling by Wnt—EP300—attention deficit hyperactivity disorder	2.08e-05	0.000146	CbGpPWpGaD
Bepridil—CALM2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.05e-05	0.000143	CbGpPWpGaD
Bepridil—CALM1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.05e-05	0.000143	CbGpPWpGaD
Bepridil—PDE1A—Disease—EP300—attention deficit hyperactivity disorder	1.98e-05	0.000138	CbGpPWpGaD
Bepridil—PDE1B—Immune System—EP300—attention deficit hyperactivity disorder	1.96e-05	0.000137	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.9e-05	0.000133	CbGpPWpGaD
Bepridil—CALM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.85e-05	0.000129	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.84e-05	0.000129	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.84e-05	0.000129	CbGpPWpGaD
Bepridil—PDE1B—Disease—EP300—attention deficit hyperactivity disorder	1.81e-05	0.000126	CbGpPWpGaD
Bepridil—CALM2—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.79e-05	0.000125	CbGpPWpGaD
Bepridil—CALM1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.79e-05	0.000125	CbGpPWpGaD
Bepridil—CALM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.76e-05	0.000123	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.75e-05	0.000122	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.75e-05	0.000122	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.72e-05	0.00012	CbGpPWpGaD
Bepridil—CALM1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.7e-05	0.000119	CbGpPWpGaD
Bepridil—CALM2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.7e-05	0.000119	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.66e-05	0.000116	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	1.65e-05	0.000115	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.65e-05	0.000115	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	1.63e-05	0.000114	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.61e-05	0.000112	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.61e-05	0.000112	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.61e-05	0.000112	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.6e-05	0.000112	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.55e-05	0.000108	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.55e-05	0.000108	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—EP300—attention deficit hyperactivity disorder	1.55e-05	0.000108	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.55e-05	0.000108	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.51e-05	0.000106	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.5e-05	0.000105	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.5e-05	0.000104	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.5e-05	0.000104	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—EP300—attention deficit hyperactivity disorder	1.48e-05	0.000104	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.47e-05	0.000103	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.45e-05	0.000102	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.45e-05	0.000101	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.45e-05	0.000101	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—EP300—attention deficit hyperactivity disorder	1.43e-05	0.0001	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—EP300—attention deficit hyperactivity disorder	1.43e-05	0.0001	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.42e-05	9.95e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.42e-05	9.95e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.41e-05	9.82e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.41e-05	9.82e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.4e-05	9.79e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—COMT—attention deficit hyperactivity disorder	1.4e-05	9.79e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—MAOA—attention deficit hyperactivity disorder	1.39e-05	9.72e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.39e-05	9.68e-05	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—EP300—attention deficit hyperactivity disorder	1.36e-05	9.52e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—COMT—attention deficit hyperactivity disorder	1.36e-05	9.47e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—COMT—attention deficit hyperactivity disorder	1.36e-05	9.47e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.35e-05	9.46e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.35e-05	9.4e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—MAOA—attention deficit hyperactivity disorder	1.35e-05	9.4e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—EP300—attention deficit hyperactivity disorder	1.33e-05	9.32e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.33e-05	9.32e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.32e-05	9.22e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.31e-05	9.15e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.31e-05	9.15e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—EP300—attention deficit hyperactivity disorder	1.29e-05	9.02e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—EP300—attention deficit hyperactivity disorder	1.29e-05	9.02e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.27e-05	8.85e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.26e-05	8.78e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	1.06e-05	7.42e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.05e-05	7.37e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	1e-05	6.99e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	9.94e-06	6.94e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.49e-06	6.63e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.18e-06	6.41e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.18e-06	6.41e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—EP300—attention deficit hyperactivity disorder	7.77e-06	5.43e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—EP300—attention deficit hyperactivity disorder	7.52e-06	5.25e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—EP300—attention deficit hyperactivity disorder	7.52e-06	5.25e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—EP300—attention deficit hyperactivity disorder	7.18e-06	5.01e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—EP300—attention deficit hyperactivity disorder	6.94e-06	4.85e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—EP300—attention deficit hyperactivity disorder	6.94e-06	4.85e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—EP300—attention deficit hyperactivity disorder	6.01e-06	4.2e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—EP300—attention deficit hyperactivity disorder	5.81e-06	4.06e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—EP300—attention deficit hyperactivity disorder	5.81e-06	4.06e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.03e-06	3.51e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.86e-06	3.4e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.86e-06	3.4e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	4.55e-06	3.18e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	4.29e-06	3e-05	CbGpPWpGaD
